日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Symptom Burden and Patient-Reported Outcomes in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Studies

肾移植受者的症状负担和患者报告结局:来自TransplantLines生物样本库和队列研究的结果

Riemersma, Niels L; Knobbe, Tim J; Kremer, Daan; Nolte, Svea; Bültmann, Ute; Annema, Coby; Shehab, Naser B N; Eisenga, Michele F; Berger, Stefan P; Bakker, Stephan J L; Annema, C; Bakker, S J L; Berger, S P; Blokzijl, H; Bodewes, F A J A; de Boer, M T; Damman; de Borst, M H; Diepstra, A; Dijkstra, G; Douwes, R M; Doorenbos, C S E; Eisenga, M F; Erasmus, M E; Gan, C T; Neto, A W Gomes; Posthumus, A M; Hak, E; Hepkema, B G; Jonker, J; Klont, F; Knobbe, T J; Kremer, D; Leuvenink, H G D; Lexmond, W S; de Meijer, V E; Nieuwenhuis-Moeke, G J; Niesters, H G M; van Pelt, L J; Pol, R A; Ranchor, A V; Sanders, J S F; Siebelink, M J; Slart, R J H J A; Swarte, J C; Touw, D J; van den Heuvel, M C; van Leer-Buter, C; van Londen, M; Te Velde-Keyzer, Charlotte A; Verschuuren, E A M; Vos, M J; Weersma, R K

Repeated HLA-DRB1 and HLA-DQB1 Mismatches Without Preformed DSA Affect Graft Survival, Rejection and DSA Development: A Multicenter Analysis

重复的HLA-DRB1和HLA-DQB1错配(无预存DSA)影响移植存活、排斥反应和DSA生成:一项多中心分析

van den Broek, D A J; Meziyerh, S; van der Helm, D; van den Born, J C; Sanders, J S F; Hepkema, B G; van de Wetering, J; van Gestel, J A Kal; Kers, J; van Kooten, C; Rotmans, J I; de Vries, A P J; Roelen, D L

Fasting before living-kidney donation: effect on donor well-being and postoperative recovery: study protocol of a multicenter randomized controlled trial

活体肾脏捐献前禁食:对捐献者健康和术后恢复的影响:一项多中心随机对照试验的研究方案

Oudmaijer, C A J; Minnee, R C; Pol, R A; van den Boogaard, W M C; Komninos, D S J; van de Wetering, J; van Heugten, M H; Hoorn, E J; Sanders, J S F; Hoeijmakers, J H J; Vermeij, W P; IJzermans, J N M

Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients

OPTIMIZE试验的原理和设计:一项开放标签、多中心、随机对照试验,比较老年患者初次肾移植时,标准免疫抑制方案(他克莫司联合吗替麦考酚酯)与低剂量他克莫司联合依维莫司的疗效。

de Boer, S E; Sanders, J S F; Bemelman, F J; Betjes, M G H; Burgerhof, J G M; Hilbrands, L; Kuypers, D; van Munster, B C; Nurmohamed, S A; de Vries, A P J; van Zuilen, A D; Hesselink, D A; Berger, S P

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant

供体特异性HLA抗体在活体供体移植和尸体供体移植中的不同作用

Kamburova, E G; Wisse, B W; Joosten, I; Allebes, W A; van der Meer, A; Hilbrands, L B; Baas, M C; Spierings, E; Hack, C E; van Reekum, F E; van Zuilen, A D; Verhaar, M C; Bots, M L; Drop, A C A D; Plaisier, L; Seelen, M A J; Sanders, J S F; Hepkema, B G; Lambeck, A J A; Bungener, L B; Roozendaal, C; Tilanus, M G J; Voorter, C E; Wieten, L; van Duijnhoven, E M; Gelens, M; Christiaans, M H L; van Ittersum, F J; Nurmohamed, S A; Lardy, N M; Swelsen, W; van der Pant, K A; van der Weerd, N C; Ten Berge, I J M; Bemelman, F J; Hoitsma, A; van der Boog, P J M; de Fijter, J W; Betjes, M G H; Heidt, S; Roelen, D L; Claas, F H; Otten, H G

Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse.

在与蛋白酶 3 抗中性粒细胞胞浆抗体相关的血管炎随访期间,血浆中可溶性白细胞介素 2 受体、可溶性 CD30、白细胞介素 10 和肿瘤坏死因子家族 B 细胞激活剂的水平:与疾病活动性和复发的关系

Sanders J-S F, Huitma M G, Kallenberg C G M, Stegeman C A